Trending Stock News

Cognizant Tech Solutions (CTSH) Holder Provident Trust Co Decreased Stake; Sarepta Therapeutics (SRPT) Holder Healthcor Management LP Has Raised Holding by $59.12 Million as Share Value Rose

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Logo

Arthur B Cohen increased its stake in Sarepta Therapeutics Inc (SRPT) by 457.43% based on its latest 2017Q4 regulatory filing with the SEC. Healthcor Management Lp bought 1.07M shares as the company’s stock rose 36.45% while stock markets declined. The hedge fund run by Arthur B Cohen held 1.31 million shares of the health care company at the end of 2017Q4, valued at $72.89M, up from 235,000 at the end of the previous reported quarter. Healthcor Management Lp who had been investing in Sarepta Therapeutics Inc for a number of months, seems to be bullish on the $5.88 billion market cap company. The stock increased 0.83% or $0.74 during the last trading session, reaching $89.7. About 624,461 shares traded. Sarepta Therapeutics, Inc. (NASDAQ:SRPT) has risen 149.90% since May 24, 2017 and is uptrending. It has outperformed by 138.35% the S&P500.

Provident Trust Co decreased its stake in Cognizant Tech Solutions (CTSH) by 23.23% based on its latest 2017Q4 regulatory filing with the SEC. Provident Trust Co sold 924,898 shares as the company’s stock rose 11.69% while stock markets declined. The institutional investor held 3.06M shares of the edp services company at the end of 2017Q4, valued at $217.04M, down from 3.98 million at the end of the previous reported quarter. Provident Trust Co who had been investing in Cognizant Tech Solutions for a number of months, seems to be less bullish one the $44.59 billion market cap company. The stock increased 0.46% or $0.35 during the last trading session, reaching $76.11. About 1.55M shares traded. Cognizant Technology Solutions Corporation (NASDAQ:CTSH) has risen 36.40% since May 24, 2017 and is uptrending. It has outperformed by 24.85% the S&P500.

Among 27 analysts covering Sarepta Therapeutics (NASDAQ:SRPT), 22 have Buy rating, 0 Sell and 5 Hold. Therefore 81% are positive. Sarepta Therapeutics had 119 analyst reports since August 5, 2015 according to SRatingsIntel. The stock of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) has “Neutral” rating given on Friday, January 15 by Piper Jaffray. Credit Suisse maintained Sarepta Therapeutics, Inc. (NASDAQ:SRPT) rating on Friday, May 4. Credit Suisse has “Outperform” rating and $92 target. Needham maintained the stock with “Buy” rating in Friday, October 2 report. RBC Capital Markets initiated the shares of SRPT in report on Monday, January 22 with “Buy” rating. Piper Jaffray maintained the shares of SRPT in report on Friday, February 9 with “Buy” rating. The rating was upgraded by Janney Capital to “Buy” on Monday, September 19. The rating was upgraded by Barclays Capital to “Overweight” on Friday, May 11. Wedbush maintained the stock with “Outperform” rating in Wednesday, July 20 report. TH Capital maintained the shares of SRPT in report on Wednesday, August 26 with “Buy” rating. The stock of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) earned “Buy” rating by Roth Capital on Thursday, August 20.

Healthcor Management Lp, which manages about $3.20B and $3.07 billion US Long portfolio, decreased its stake in Livanova Plc by 308,533 shares to 622,997 shares, valued at $49.79M in 2017Q4, according to the filing. It also reduced its holding in Zimmer Biomet Hldgs Inc (Call) (ZMH) by 150,000 shares in the quarter, leaving it with 100,000 shares, and cut its stake in Tenet Healthcare Corp (NYSE:THC).

More notable recent Sarepta Therapeutics, Inc. (NASDAQ:SRPT) news were published by: Nasdaq.com which released: “Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)” on April 30, 2018, also Seekingalpha.com with their article: “The Market Has Spoken: Buy Sarepta” published on May 07, 2018, Seekingalpha.com published: “Premarket analyst action – healthcare” on May 11, 2018. More interesting news about Sarepta Therapeutics, Inc. (NASDAQ:SRPT) were released by: Seekingalpha.com and their article: “Wave Life Sciences: What’s Cooking Behind This Innovator?” published on May 23, 2018 as well as Nasdaq.com‘s news article titled: “Sarepta Therapeutics Announces Partnership with Myonexus Therapeutics for the Advancement of Multiple Gene …” with publication date: May 03, 2018.

Investors sentiment decreased to 1.22 in 2017 Q4. Its down 1.66, from 2.88 in 2017Q3. It worsened, as 27 investors sold SRPT shares while 67 reduced holdings. 45 funds opened positions while 70 raised stakes. 52.88 million shares or 2.28% more from 51.70 million shares in 2017Q3 were reported. Crow Point Prtn Limited Liability Company has 1,302 shares. Point72 Asset LP holds 0.14% of its portfolio in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) for 579,757 shares. Pointstate Capital Limited Partnership holds 0.26% or 485,400 shares in its portfolio. Parametric Assoc Limited Liability invested in 152,386 shares or 0.01% of the stock. Quantbot Technology LP has invested 0% of its portfolio in Sarepta Therapeutics, Inc. (NASDAQ:SRPT). Hanson Mcclain has 699 shares for 0% of their portfolio. Jefferies Group Inc Ltd Liability Corporation has 40,000 shares. Royal Bancorporation Of Canada has invested 0.01% of its portfolio in Sarepta Therapeutics, Inc. (NASDAQ:SRPT). Jpmorgan Chase & owns 435,229 shares. Ameritas Investment Prtn owns 5,161 shares for 0.01% of their portfolio. Pictet Asset Management Ltd holds 0.01% or 40,200 shares in its portfolio. Polar Llp reported 0.01% in Sarepta Therapeutics, Inc. (NASDAQ:SRPT). 45,010 were reported by Blair William & Company Il. Camber Capital Mngmt Limited Liability Company reported 300,000 shares. First Manhattan Company has invested 0% in Sarepta Therapeutics, Inc. (NASDAQ:SRPT).

Investors sentiment increased to 1.19 in 2017 Q4. Its up 0.16, from 1.03 in 2017Q3. It is positive, as 46 investors sold CTSH shares while 285 reduced holdings. 107 funds opened positions while 288 raised stakes. 491.94 million shares or 0.85% more from 487.81 million shares in 2017Q3 were reported. Glenmede Trust Na has 2.44 million shares for 0.72% of their portfolio. 54,569 are owned by Huntington National Bank. Howland Management Limited Liability Co accumulated 0.22% or 38,944 shares. Fiera Corporation reported 252,000 shares. Ledyard Comml Bank has 1,093 shares for 0.01% of their portfolio. Cambridge Company stated it has 0.66% of its portfolio in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). Flossbach Von Storch Ag stated it has 0.23% in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). Fincl Mngmt Professionals holds 17 shares or 0% of its portfolio. Columbia Asset Mngmt owns 0.08% invested in Cognizant Technology Solutions Corporation (NASDAQ:CTSH) for 3,700 shares. Fiduciary holds 0.1% or 48,462 shares. Oppenheimer Asset Mngmt Incorporated accumulated 50,631 shares. Mirae Asset Glob Investments Comm Ltd invested 0.06% of its portfolio in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). Cornerstone Mngmt Hldgs holds 0.13% or 254,717 shares. Bank Of Montreal Can invested 0.03% in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). Rothschild Asset Mgmt reported 287,998 shares.

Since December 7, 2017, it had 1 insider purchase, and 40 insider sales for $51.92 million activity. On Tuesday, January 16 RAMAKRISHNAN CHANDRASEKARAN sold $1.89M worth of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) or 25,000 shares. Another trade for 1,278 shares valued at $91,198 was sold by Middleton Sean. fox John nelson JR sold $478,981 worth of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) on Wednesday, February 14. The insider GOMATAM SUMITHRA sold 1,060 shares worth $85,326. CHATTERJEE DEBASHIS had sold 1,726 shares worth $136,354 on Wednesday, February 7. Another trade for 34,000 shares valued at $2.69 million was made by Mehta Rajeev on Wednesday, February 7.

Provident Trust Co, which manages about $2.45B US Long portfolio, upped its stake in Fastenal Inc Com (NASDAQ:FAST) by 19,184 shares to 999,061 shares, valued at $54.64 million in 2017Q4, according to the filing. It also increased its holding in Southwest Airlines (NYSE:LUV) by 14,250 shares in the quarter, for a total of 2.68 million shares, and has risen its stake in Tjx Companies Inc (NYSE:TJX).

More news for Cognizant Technology Solutions Corporation (NASDAQ:CTSH) were recently published by: Prnewswire.com, which released: “Cognizant Interactive Among Top of Ad Age’s Agency Report 2018 Rankings” on May 24, 2018. Investingnews.com‘s article titled: “Harvest Rebalances Blockchain ETF” and published on May 23, 2018 is yet another important article.

Cognizant Technology Solutions Corporation (NASDAQ:CTSH) Institutional Positions Chart

Ash

Leave a Reply

Your email address will not be published. Required fields are marked *